BNGOW (Bionano Genomics) EPS (Basic): $0.00 (TTM As of Mar. 2026)

What is Bionano Genomics EPS (Basic)?

Bionano Genomics BNGOW 64 EPS (Basic) is $0.00 as of Mar. 2026. GuruFocus rates BNGOW with a GF Score™ of 64/100. The stock has 3 warning signs investors should review.

Bionano Genomics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

Bionano Genomics's EPS (Diluted) for the three months ended in Mar. 2026 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

Bionano Genomics's EPS without NRI for the three months ended in Mar. 2026 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 74.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 46.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Bionano Genomics's highest 3-Year average EPS without NRI Growth Rate was 74.00% per year. The lowest was -8.70% per year. And the median was 38.00% per year.

Bionano Genomics (NAS:BNGOW) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bionano Genomics EPS (Basic) Related Terms

Bionano Genomics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Bionano Genomics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionano Genomics EPS (Basic) Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

0.00

Bionano Genomics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

64GF Score

Bionano Genomics Inc BNGOW

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bionano Genomics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bionano Genomics's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-26.395	-	0)	/	0
	=

Bionano Genomics's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-8.303	-	0)	/	0
	=

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of $0.00 mean?

Bionano Genomics (BNGOW) has a EPS (Basic) of $0.00 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bionano Genomics and its competitors.

Is Bionano Genomics' EPS (Basic) too high?

Bionano Genomics' current EPS (Basic) is $0.00. Overall, Bionano Genomics has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.

How does Bionano Genomics' EPS (Basic) compare to UEEC and ZJYL?

Bionano Genomics' EPS (Basic) of $0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Devices & Instruments company?

A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bionano Genomics and its competitors. Bionano Genomics's current EPS (Basic) is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bionano Genomics stock overvalued right now?

Bionano Genomics (BNGOW) has a current EPS (Basic) of $0.00. The current EPS (Basic) is $0.00. Bionano Genomics' overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Bionano Genomics (BNGOW), the current EPS (Basic) is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionano Genomics Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies UEEC ZJYL RGNT RVP MHUAF LUCY CUPR NXGL CBSC FEMY ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Other Exchanges BNGO:USA BNGO:Mexico

Address 9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website https://www.bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

64GF Score

Get the complete analysis for BNGOW

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View BNGOW Analysis

See EPS (Basic) data for all stocks →